|
Market Closed -
Other stock markets
|
After hours 03:59:58 pm | |||
| 48.26 EUR | -0.25% |
|
48.11 | -0.31% |
| Jan. 14 | Recordati Industria Chimica e Farmaceutica S.p.A. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 11:15 AM | |
| Jan. 12 | Recordati Acquires 74,165 Own Ordinary Shares | AN |
Company Valuation: Recordati
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 9,330 | 11,657 | 7,959 | 10,042 | 10,347 | 9,872 | 9,872 | - |
| Change | - | 24.95% | -31.72% | 26.16% | 3.04% | -4.58% | 0% | - |
| Enterprise Value (EV) 1 | 10,195 | 12,405 | 9,379 | 11,621 | 12,501 | 11,797 | 11,607 | 11,346 |
| Change | - | 21.67% | -24.39% | 23.9% | 7.57% | -5.63% | -1.62% | -2.25% |
| P/E ratio | 26.7x | 30.6x | 25.9x | 26.2x | 25.4x | 21.6x | 18.6x | 16x |
| PBR | 7.33x | 8.42x | 5.15x | 6.06x | 5.64x | 4.91x | 4.56x | 4.06x |
| PEG | - | 3.51x | -1.4x | 1.1x | 3.61x | 1.8x | 1.2x | 1x |
| Capitalization / Revenue | 6.44x | 7.38x | 4.29x | 4.82x | 4.42x | 3.76x | 3.52x | 3.28x |
| EV / Revenue | 7.04x | 7.85x | 5.06x | 5.58x | 5.34x | 4.5x | 4.14x | 3.77x |
| EV / EBITDA | 17.9x | 20.6x | 13.9x | 15.1x | 14.4x | 12.2x | 11.3x | 9.96x |
| EV / EBIT | 21.7x | 25.3x | 21.4x | 20.8x | 18.3x | 15.6x | 13.9x | 12.1x |
| EV / FCF | 26.7x | 26.4x | 21.4x | 25.5x | 23.4x | 18.9x | 17.3x | 15.1x |
| FCF Yield | 3.75% | 3.79% | 4.68% | 3.92% | 4.28% | 5.3% | 5.79% | 6.61% |
| Dividend per Share 2 | 1.05 | 1.1 | 1.15 | 1.2 | 1.27 | 1.451 | 1.608 | 1.809 |
| Rate of return | 2.32% | 1.95% | 2.97% | 2.46% | 2.51% | 3.01% | 3.33% | 3.75% |
| EPS 2 | 1.698 | 1.846 | 1.494 | 1.861 | 1.992 | 2.236 | 2.594 | 3.019 |
| Distribution rate | 61.8% | 59.6% | 77% | 64.5% | 63.8% | 64.9% | 62% | 59.9% |
| Net sales 1 | 1,449 | 1,580 | 1,853 | 2,082 | 2,342 | 2,622 | 2,802 | 3,010 |
| EBITDA 1 | 569.3 | 602.3 | 672.8 | 769.6 | 865.8 | 970.9 | 1,028 | 1,139 |
| EBIT 1 | 469 | 490.2 | 437.3 | 558 | 684.4 | 755.2 | 833.7 | 939.7 |
| Net income 1 | 355 | 386 | 312.3 | 389.2 | 416.5 | 493.8 | 562.7 | 651.2 |
| Net Debt 1 | 865.8 | 747.6 | 1,420 | 1,579 | 2,154 | 1,925 | 1,734 | 1,474 |
| Reference price 2 | 45.33 | 56.50 | 38.75 | 48.83 | 50.60 | 48.26 | 48.26 | 48.26 |
| Nbr of stocks (in thousands) | 205,817 | 206,325 | 205,406 | 205,645 | 204,479 | 204,565 | 204,565 | - |
| Announcement Date | 2/22/21 | 2/24/22 | 2/21/23 | 2/22/24 | 2/13/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.62x | 4.5x | 12.15x | 3% | 11.53B | |
| 46.89x | 15.52x | 34.45x | 0.55% | 961B | |
| 21.23x | 5.89x | 16.39x | 2.36% | 527B | |
| 75.19x | 7.36x | 17.64x | 2.95% | 392B | |
| 20.01x | 5x | 12.44x | 2.87% | 368B | |
| 29.15x | 5.47x | 16.22x | 1.67% | 299B | |
| 20.36x | 5.38x | 12.6x | 2.81% | 279B | |
| 14.22x | 4.66x | 10.01x | 2.91% | 276B | |
| 16.39x | 5.8x | 11.99x | 3.08% | 262B | |
| 25.73x | 6.1x | 10.45x | 2.91% | 177B | |
| Average | 29.08x | 6.57x | 15.44x | 2.51% | 355.22B | |
| Weighted average by Cap. | 33.93x | 8.39x | 19.56x | 2.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- REC Stock
- Valuation Recordati
Select your edition
All financial news and data tailored to specific country editions
